![Daniel Getts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Getts
Gründer bei Myeloid Therapeutics, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michael D. Grisham | M | - |
Curate Biosciences
![]() Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | 22 Jahre |
Thomas Cahill | M | 37 |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 5 Jahre |
Margaret Siegel | F | - | 6 Jahre | |
David Backer | M | - |
Curate Biosciences
![]() Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | - |
Daniel Geffken | M | 67 |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | - |
Elaine Jones | M | 69 |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 3 Jahre |
Brett Ilan Kaplan | M | 50 |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 2 Jahre |
Mayo Pujols | M | 55 |
Curate Biosciences
![]() Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | 2 Jahre |
Stanley Frankel | M | 65 |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 2 Jahre |
Richard Roomberg | M | - | 5 Jahre | |
Kevin Zikaras | M | - | 6 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Neil Gibson | M | 67 | 5 Jahre | |
Andrew Allen | M | 57 | 5 Jahre | |
Bruce McCreedy | M | 64 |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 5 Jahre |
Mayur Ian Somaiya | M | 50 | 3 Jahre | |
Wei Li | M | 52 | - | |
Steven Turkowiak | M | - | - | |
Alfonso Quintás-Cardama | M | 53 | - | |
Ronald Vale | M | - |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | - |
Yuxiao Wang | M | - |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 20 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Daniel Getts
- Persönliches Netzwerk